# A 16 Week Study of HRS-7535 in Adults With Type 2 Diabetes Mellitus

> **NCT05759897** · PHASE2 · UNKNOWN · sponsor: **Shandong Suncadia Medicine Co., Ltd.** · enrollment: 180 (estimated)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** HRS-7535
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05759897
- **Lead sponsor:** Shandong Suncadia Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02-28
- **Primary completion:** 2023-12-21
- **Final completion:** 2024-01-04
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2023-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05759897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05759897, "A 16 Week Study of HRS-7535 in Adults With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05759897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*